WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Phillip S. McGill
Partner
Corporate
San Diego
pmcgill@wsgr.com

D858-350-2249

Download vCard
Open PDF
  • Long-Term Focus

    The foundation of Phil’s practice is long-term, relationship-building as a trusted adviser to founders, executives, and board members throughout the corporate life cycle. 

  • Broad Corporate and Transactional Experience

    Phil’s practice covers a broad range of corporate and transactional matters, serving as outside general counsel and transaction-specific counsel to private and public companies in a variety of industries at all stages of their growth. 

Phillip (Phil) McGill is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he represents clients on corporate and securities law matters in the life sciences and technology sectors. His practice is focused on being a strategic partner to companies throughout each phase of the corporate life cycle, with an emphasis on guiding companies through late-stage financings and exits, as well as post-IPO public company representation. He has particular expertise collaborating with venture capital firms and universities as counsel to companies formed through their discovery engine and incubator programs.

Private companies rely on Phil for his company-building experience, which includes pre-incorporation planning; navigating seed, venture capital, growth and cross-over stage financings; planning and executing IPOs; continued post-IPO public company representation; and executing mergers and acquisitions. Phil has extensive experience advising small, mid, and large cap public companies on complex capital markets transactions; nuanced SEC and securities exchange reporting and compliance; complicated corporate governance and investor relations matters; and significant strategic transactions.

Prior to his legal career, Phil was an associate in the tax services group of PricewaterhouseCoopers, which advised strategic and private equity clients on corporate tax aspects of mergers and acquisitions. Phil has a background in finance and accounting, with an academic interest in financial markets.

Experience

Phillip (Phil) McGill is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he represents clients on corporate and securities law matters in the life sciences and technology sectors. His practice is focused on being a strategic partner to companies throughout each phase of the corporate life cycle, with an emphasis on guiding companies through late-stage financings and exits, as well as post-IPO public company representation. He has particular expertise collaborating with venture capital firms and universities as counsel to companies formed through their discovery engine and incubator programs.

Private companies rely on Phil for his company-building experience, which includes pre-incorporation planning; navigating seed, venture capital, growth and cross-over stage financings; planning and executing IPOs; continued post-IPO public company representation; and executing mergers and acquisitions. Phil has extensive experience advising small, mid, and large cap public companies on complex capital markets transactions; nuanced SEC and securities exchange reporting and compliance; complicated corporate governance and investor relations matters; and significant strategic transactions.

Prior to his legal career, Phil was an associate in the tax services group of PricewaterhouseCoopers, which advised strategic and private equity clients on corporate tax aspects of mergers and acquisitions. Phil has a background in finance and accounting, with an academic interest in financial markets.

Education
  • J.D., University of San Diego School of Law, 2013

    Magna Cum Laude, Order of the Coif

  • B.A., Political Science, University of California, Irvine, 2008

    Minor in Accounting, Cum Laude, Eckstein Award for Outstanding Honors Thesis (“The Increasing Threat of Global Financial Crises”)

Honors
  • Honored among San Diego Business Journal’s “40 Next Top Business Leaders Under 40”
  • Named to the 2025 and 2026 Lawdragon “500 X – The Next Generation” lists
  • Recognized as a “Rising Star” by San Diego Super Lawyers each year since 2017
Admissions
  • State Bar of California
Credentials
Education
  • J.D., University of San Diego School of Law, 2013

    Magna Cum Laude, Order of the Coif

  • B.A., Political Science, University of California, Irvine, 2008

    Minor in Accounting, Cum Laude, Eckstein Award for Outstanding Honors Thesis (“The Increasing Threat of Global Financial Crises”)

Honors
  • Honored among San Diego Business Journal’s “40 Next Top Business Leaders Under 40”
  • Named to the 2025 and 2026 Lawdragon “500 X – The Next Generation” lists
  • Recognized as a “Rising Star” by San Diego Super Lawyers each year since 2017
Admissions
  • State Bar of California
Focus Areas
  • Biotech
  • Capital Markets
  • Corporate
  • Corporate Governance
  • Corporate Life Sciences
  • Emerging Companies and Venture Capital
  • Life Sciences
  • Public Company Representation
Recent Insights
News Articles
Wilson Sonsini Attorneys Named to Lawdragon’s 2026 List of Next-Generation Lawyers
Ten Wilson Sonsini attorneys have been recognized in the 2026 edition of Lawdragon 500 X – The Next Generation. Individuals listed in the guide are “the future of the law” and are recognized for their accomplishments in their career thus far.
Learn More
Client Highlights
Wilson Sonsini Advises OnKure Therapeutics on $150 Million Private Placement
On March 27, 2026, OnKure Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel precision medicines, announced that it has entered into a securities purchase agreement for a private placement with certain institutional and accredited healthcare investors, raising gross proceeds of approximately $150 million. Wilson Sonsini Goodrich & Rosati advised OnKure on the transaction.
Learn More
View All
Recent Events
Affiliated Programs
NextGen VC Forum - NYC 2024
LaunchBio’s NextGen VC Forum is the premiere event for mid-level venture capital associates to expand their skills and expertise while growing their network. Attendees benefit from curated education sessions from industry leaders to supplement existing expertise. Networking is essential in sourcing deals and one of the primary roles for associates, we’ve built it into the program for participants to be able to walk away with new life science and biotech contacts. The half-day forum created with Wilson Sonsini includes a networking lunch, three one-hour sessions, and a happy hour.
Learn More
Affiliated Programs
NextGen VC Forum - Boston
LaunchBio’s NextGen VC Forum is the premiere event for mid-level venture capital associates to expand their skills and expertise while growing their network. Attendees benefit from curated education sessions from industry leaders to supplement existing expertise. Networking is essential in sourcing deals and one of the primary roles for associates, we’ve built it into the program for participants to be able to walk away with new life science and biotech contacts. The half-day forum created with Wilson Sonsini includes a networking lunch, three one-hour sessions, and a happy hour. View the event flyer here.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.